Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.

Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, Spector N, Molina-Kirsch HF, Warnke RA, Levy R, Natkunam Y.

Am J Pathol. 2012 Sep;181(3):795-803. doi: 10.1016/j.ajpath.2012.05.015.

2.

CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.

Zhao S, Zhang H, Xing Y, Natkunam Y.

Am J Surg Pathol. 2013 Feb;37(2):250-8. doi: 10.1097/PAS.0b013e318268c6ea.

PMID:
23095505
3.

Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.

Narducci MG, Pescarmona E, Lazzeri C, Signoretti S, Lavinia AM, Remotti D, Scala E, Baroni CD, Stoppacciaro A, Croce CM, Russo G.

Cancer Res. 2000 Apr 15;60(8):2095-100.

4.

Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.

Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M.

Blood. 1998 Aug 15;92(4):1308-16.

5.

Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.

Yoon SO, Kim WY, Go H, Paik JH, Kim JE, Kim YA, Huh JR, Jeon YK, Kim CW.

Am J Surg Pathol. 2010 May;34(5):645-55. doi: 10.1097/PAS.0b013e3181d5d903.

PMID:
20220512
6.

Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.

Kondratiev S, Duraisamy S, Unitt CL, Green MR, Pinkus GS, Shipp MA, Kutok JL, Drapkin RI, Rodig SJ.

Am J Surg Pathol. 2011 Oct;35(10):1531-9. doi: 10.1097/PAS.0b013e31822bd476.

7.

Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.

Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ.

Am J Surg Pathol. 2006 Jul;30(7):802-10.

8.

Expression of CD137 (4-1BB) on human follicular dendritic cells.

Lindstedt M, Johansson-Lindbom B, Borrebaeck CA.

Scand J Immunol. 2003 Apr;57(4):305-10.

9.

BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.

Takahata H, Ohara N, Ichimura K, Tanaka T, Sato Y, Morito T, Takata K, Kojima M, Kobata T, Yoshino T.

J Clin Exp Hematop. 2010;50(2):121-7.

10.

Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression.

Ho WT, Pang WL, Chong SM, Castella A, Al-Salam S, Tan TE, Moh MC, Koh LK, Gan SU, Cheng CK, Schwarz H.

Cancer Res. 2013 Jan 15;73(2):652-61. doi: 10.1158/0008-5472.CAN-12-3849. Epub 2012 Nov 29.

11.

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T.

Blood. 2003 Nov 15;102(10):3753-8. Epub 2003 Jul 24.

12.

CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.

Bellan C, De Falco G, Lazzi S, Micheli P, Vicidomini S, Schürfeld K, Amato T, Palumbo A, Bagella L, Sabattini E, Bartolommei S, Hummel M, Pileri S, Tosi P, Leoncini L, Giordano A.

J Pathol. 2004 Aug;203(4):946-52.

PMID:
15258998
13.

Use of CD137 ligand expression in the detection of small B-cell lymphomas involving the bone marrow.

Zhao S, Xing Y, Natkunam Y.

Hum Pathol. 2014 May;45(5):1024-30. doi: 10.1016/j.humpath.2013.12.019. Epub 2014 Jan 21.

PMID:
24746207
14.

Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.

Sun Y, Blink SE, Chen JH, Fu YX.

J Immunol. 2005 Jul 15;175(2):884-90.

15.

Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.

Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ.

Mod Pathol. 2004 Aug;17(8):954-61.

16.

Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma.

Middendorp S, Xiao Y, Song JY, Peperzak V, Krijger PH, Jacobs H, Borst J.

Blood. 2009 Sep 10;114(11):2280-9. doi: 10.1182/blood-2009-03-208215. Epub 2009 Jul 16.

17.

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.

Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T.

Haematologica. 2007 Aug;92(8):1059-66. Epub 2007 Jul 20.

18.

CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers.

Pauly S, Broll K, Wittmann M, Giegerich G, Schwarz H.

J Leukoc Biol. 2002 Jul;72(1):35-42.

PMID:
12101260
19.

Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.

Nguyen PL, Harris NL, Ritz J, Robertson MJ.

Am J Pathol. 1996 Mar;148(3):847-53. Erratum in: Am J Pathol 1996 Jul;149(1):346.

20.

Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.

Sanchez-Paulete AR, Labiano S, Rodriguez-Ruiz ME, Azpilikueta A, Etxeberria I, Bolaños E, Lang V, Rodriguez M, Aznar MA, Jure-Kunkel M, Melero I.

Eur J Immunol. 2016 Mar;46(3):513-22. doi: 10.1002/eji.201445388. Epub 2016 Feb 9. Review.

Supplemental Content

Support Center